Company / Interest Expense
Vaxcyte, Inc. Interest Expense History
FY2018-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
-
FY2023
5-year range
$0 / $7.0K
FY2019-FY2023
Trend
-100.0%
vs FY2022
Sector context
#40 of 44
Health Care
What the data says
Improved from $7,000 to $0 over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 44
▼
Key checks
Key Insights
- In FY2023, interest expense decreased 100.0% year-over-year.
- Peak interest expense was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.94 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0 | -100.0% |
| FY2022 | $2.0K | -71.4% |
| FY2021 | $7.0K | +0.0% |
| FY2020 | $7.0K | -82.5% |
| FY2019 | $40.0K | -46.7% |
| FY2018 | $75.0K | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026